Anti-Asthma TDM Assay Kits Market Size

Anti-Asthma TDM Assay Kits Market size was over USD 19.04 Billion in 2023 and is likely to reach USD 39.63 Billion by the end of 2036, growing at around 5.8% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of anti-asthma TDM assay kits is assessed at USD 20.03 Billion. The growth of the market can be attributed to the escalating cases of asthma worldwide. TDM is used to measure the plasma concentration of the drug in the given therapy, and it involves measuring drug concentration and clinical interpretation of the result. Asthma is thought to affect at least 300 million individuals worldwide, 30 million of whom reside in mainland China.

In addition to these, factors that are believed to fuel the market growth of anti-asthma TDM assay kits include the rise in the consumption of tobacco. Scientists claim that tobacco smoke is a common trigger for asthma. The smoke from tobacco products, such as cigars, cigarettes, or pipes can aggravate the condition. The data released by the World Health Organization states that in 2020, 22.3% of the world population used tobacco. On account of excessively increasing tobacco users, the global anti-asthma TDM assay kits market is estimated to grow during the forecast period. Also, the worsening air quality is causing various respiratory diseases and asthma is the most common of all. This is also estimated to fuel the global anti-asthma TDM assay kits market growth during the forecast period. The World Health Organization (WHO) estimates that, as of 2019, 99% of the world's population resided in areas where the WHO's air quality standards were not being met. According to data from the same year, more than 90% of individuals worldwide lived in regions where PM2.5 concentrations were higher than the WHO annual air quality criteria (AQG), which are 10 g/m3.